MI This Month: The Case for Clinical Trials of Therapeutic Cancer Vaccines in the Prophylactic Setting
A groundbreaking study by Jaini et al. recently demonstrated that prophylactic immunization against a breast cancer associated antigen can prevent tumor development... [8/31/2010]
Read more
JPET Highlight: Preventing Doxorubicin Cardiotoxicity through the Selective Inhibition of Phosphodiesterase 5
Antineoplastic therapy using anthracyclines (e.g., Doxorubicin) is limited by cardiotoxicity, but results by Koka et al suggest that prophylactic treatment with tadalafil might be able to limit this toxicity... [8/26/2010]
Read more
Neuropharmacology Division Blog & Facebook Page
Thanks to efforts by Hibah Awwad and Badr Mostafa, the ASPET
Neuropharmacology Division now has its own blog and a presence on
Facebook... [8/16/2010]
Read more
JPET Highlight: Dopamine D2 or D3 Antagonism for Treating Cocaine Addiction?
Achat-Mendes et al. found that D3-selective antagonists may blunt some
aspects of the subjective effects of cocaine and forestall relapse in
abstinent cocaine abusers... [7/29/2010]
Read more
DMD Highlight: Methadone is an Inactivating Substrate for Aromatase
A report by Lu et al in the August 2010 issue of DMD is the first known connection between methadone
and steroid metabolism... [7/25/2010]
Read more
Poll Results: Things I Wish I Learned in Graduate School
We asked you to tell us which things you feel are lacking in current Pharmacology Graduate education. At least two clear themes seemed to emerge... [7/12/2010]
Read more
MI This Month: Getting down to the bone...
In the June 2010 issue of Molecular Interventions, Drake and Cremers discuss the use of biphosphonates to treat bone
disease while Schmidt et al review mechanisms and treatment of bone (and other) pain in cancer patients... [6/17/2010]
Read more